Find Teduglutide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Chebi:72305, Teduglutide (rdna origin), Chembl2104987, Bdbm50183895
Molecular Formula
C164H252N44O55S
Molecular Weight
3752.1  g/mol
InChI Key
CILIXQOJUNDIDU-ASQIGDHWSA-N

Teduglutide
1 2D Structure

Teduglutide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]butanedioic acid
2.1.2 InChI
InChI=1S/C164H252N44O55S/c1-21-77(11)126(156(255)187-95(44-46-114(167)214)141(240)206-130(83(17)211)160(259)186-93(42-33-34-49-165)140(239)202-129(80(14)24-4)159(258)208-131(84(18)212)161(260)200-111(163(262)263)66-125(230)231)203-151(250)100(54-76(9)10)189-145(244)103(57-88-67-175-92-41-32-31-40-90(88)92)192-147(246)105(60-116(169)216)199-157(256)127(78(12)22-2)204-152(251)102(56-87-38-29-26-30-39-87)190-149(248)109(64-123(226)227)195-137(236)94(43-35-50-174-164(171)172)183-134(233)82(16)179-133(232)81(15)180-142(241)98(52-74(5)6)188-146(245)104(59-115(168)215)194-150(249)110(65-124(228)229)196-143(242)99(53-75(7)8)198-158(257)128(79(13)23-3)205-162(261)132(85(19)213)207-153(252)106(61-117(170)217)193-139(238)97(48-51-264-20)185-138(237)96(45-47-120(220)221)184-148(247)108(63-122(224)225)197-155(254)113(72-210)201-144(243)101(55-86-36-27-25-28-37-86)191-154(253)112(71-209)182-119(219)70-177-136(235)107(62-121(222)223)181-118(218)69-176-135(234)91(166)58-89-68-173-73-178-89/h25-32,36-41,67-68,73-85,91,93-113,126-132,175,209-213H,21-24,33-35,42-66,69-72,165-166H2,1-20H3,(H2,167,214)(H2,168,215)(H2,169,216)(H2,170,217)(H,173,178)(H,176,234)(H,177,235)(H,179,232)(H,180,241)(H,181,218)(H,182,219)(H,183,233)(H,184,247)(H,185,237)(H,186,259)(H,187,255)(H,188,245)(H,189,244)(H,190,248)(H,191,253)(H,192,246)(H,193,238)(H,194,249)(H,195,236)(H,196,242)(H,197,254)(H,198,257)(H,199,256)(H,200,260)(H,201,243)(H,202,239)(H,203,250)(H,204,251)(H,205,261)(H,206,240)(H,207,252)(H,208,258)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,262,263)(H4,171,172,174)/t77-,78-,79-,80-,81-,82-,83+,84+,85+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,126-,127-,128-,129-,130-,131-,132-/m0/s1
2.1.3 InChI Key
CILIXQOJUNDIDU-ASQIGDHWSA-N
2.1.4 Canonical SMILES
CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CNC=N5)N
2.1.5 Isomeric SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC5=CNC=N5)N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Chebi:72305

2. Teduglutide (rdna Origin)

3. Chembl2104987

4. Bdbm50183895

2.3 Create Date
2013-02-04
3 Chemical and Physical Properties
Molecular Weight 3752.1 g/mol
Molecular Formula C164H252N44O55S
XLogP3-15.2
Hydrogen Bond Donor Count55
Hydrogen Bond Acceptor Count60
Rotatable Bond Count126
Exact Mass3750.8028943 g/mol
Monoisotopic Mass3749.7995395 g/mol
Topological Polar Surface Area1650 Ų
Heavy Atom Count264
Formal Charge0
Complexity9030
Isotope Atom Count0
Defined Atom Stereocenter Count38
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702837800,"product":"TEDUGLUTIDE API","address":"CAMUS HOUSE, 29-B,","city":"JAIPUR, RAJASTHAN.","supplier":"CAMUS PHARMA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"PSK PHARMA LTD","customerCountry":"RUSSIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"279500000","totalValueFC":"83922.8","currency":"INR","unitRateINR":279440000,"date":"18-Dec-2023","totalValueINR":"6986000","totalValueInUsd":"83922.8","indian_port":"Bombay Air","hs_no":"29379020","bill_no":"6126738","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CAMUS HOUSE, 29-B,, JAIPUR, RAJASTHAN.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706725800,"product":"TEDUGLUTIDE API","address":"CAMUS HOUSE, 29-B,","city":"JAIPUR, RAJASTHAN.","supplier":"CAMUS PHARMA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"PSK PHARMA LTD","customerCountry":"RUSSIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"279500000","totalValueFC":"83976.8","currency":"INR","unitRateINR":278714800,"date":"01-Feb-2024","totalValueINR":"6967870","totalValueInUsd":"83976.8","indian_port":"Bombay Air","hs_no":"29379020","bill_no":"7182056","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CAMUS HOUSE, 29-B,, JAIPUR, RAJASTHAN.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710786600,"product":"TEDUGLUTIDE FRAGMENT1-30 (QTY:90 MG)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"SHANGHAI - PU DONG","customer":"NANJING KING FRIEND BIOCHEMICAL","customerCountry":"CHINA","quantity":"0.00","actualQuantity":"0.09","unit":"GMS","unitRateFc":"100000","totalValueFC":"8862.7","currency":"USD","unitRateINR":8176859.555555556,"date":"19-Mar-2024","totalValueINR":"735917.36","totalValueInUsd":"8862.7","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"8451862","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737570600,"product":"(1-30)-TEDUGLUTIDE(PHARMA STANDARDS)(QTY:50 MGS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MILAN - MALPENSA","customer":"ATTNKATIA LEVA","customerCountry":"ITALY","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"96000","totalValueFC":"2971.2","currency":"USD","unitRateINR":5124000,"date":"23-Jan-2025","totalValueINR":"256200","totalValueInUsd":"2971.2","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"7541565","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737570600,"product":"ISO-ASP-TEDUGLUTIDE(PHARMA STANDARDS)(QTY:50 MGS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MILAN - MALPENSA","customer":"ATTNKATIA LEVA","customerCountry":"ITALY","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"88000","totalValueFC":"2476","currency":"USD","unitRateINR":4270000,"date":"23-Jan-2025","totalValueINR":"213500","totalValueInUsd":"2476","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"7540787","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742495400,"product":"TEDUGLUTIDE(KW)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"JSC PHARMASYNTEZ","customerCountry":"RUSSIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"344000000","totalValueFC":"97623.8","currency":"INR","unitRateINR":338237406,"date":"21-Mar-2025","totalValueINR":"8455935.15","totalValueInUsd":"97623.8","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"9215708","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1743445800,"product":"TEDUGLUTIDE API, BATCH NO.:- KW0051124,QTY:- 15 MG OTHER AS PER INV","address":"882\/1-871, NEAR KANKAVATI ,VILLAGE-","city":"AHMEDABAD, GUJARAT","supplier":"AMNEAL PHARMACEUTICALS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"CAT GMBH CO KG","customerCountry":"GERMANY","quantity":"0.00","actualQuantity":"0.015","unit":"GMS","unitRateFc":"1704","totalValueFC":"25.6","currency":"USD","unitRateINR":145862,"date":"01-Apr-2025","totalValueINR":"2187.93","totalValueInUsd":"25.6","indian_port":"Ahmedabad Air","hs_no":"29379020","bill_no":"9572329","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"882\/1-871, NEAR KANKAVATI ,VILLAGE-, AHMEDABAD, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745346600,"product":"TEDUGLUTIDE(QTY:2 GMS)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"AMPHASTAR PHARMACEUTICALS","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"2","unit":"GMS","unitRateFc":"4700","totalValueFC":"6926.3","currency":"USD","unitRateINR":296450,"date":"23-Apr-2025","totalValueINR":"592900","totalValueInUsd":"6926.3","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"1193889","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1753813800,"product":"PHARMA STANDARDS : MET(O) -TEDUGLUTIDE (AS PER INVOICE)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"ATTEN : ICSES MARTINEZ","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"918180","totalValueFC":"741.6","currency":"USD","unitRateINR":63824940,"date":"30-Jul-2025","totalValueINR":"63824.94","totalValueInUsd":"741.6","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"4008625","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1753813800,"product":"PHARMA STANDARDS : [(1-30)-TEDUGLUTIDE (AS PER INVOICE)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"ATTEN : ICSES MARTINEZ","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"918180","totalValueFC":"741.6","currency":"USD","unitRateINR":63824940,"date":"30-Jul-2025","totalValueINR":"63824.94","totalValueInUsd":"741.6","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"4008625","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1753986600,"product":"TEDUGLUTIDE","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"AMEDART LLC","customerCountry":"RUSSIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"4800","totalValueFC":"22935.4","currency":"USD","unitRateINR":401459.73599999998,"date":"01-Aug-2025","totalValueINR":"2007298.68","totalValueInUsd":"22935.4","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"4080166","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1757961000,"product":"TEDUGLUTIDE(KW)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"AMPHASTAR PHARMACEUTICALS","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"10","unit":"GMS","unitRateFc":"3500","totalValueFC":"34615.8","currency":"USD","unitRateINR":305549.98800000001,"date":"16-Sep-2025","totalValueINR":"3055499.88","totalValueInUsd":"34615.8","indian_port":"Hyderabad Air","hs_no":"29371900","bill_no":"5326533","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655404200,"product":"TEDUGLUTIDE, 802533G (1 X 2.45 GMS)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"CHINESE PEPTIDE CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS PRIVATE LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00245","unit":"KGS","unitRateFc":"3800000","totalValueFC":"11681.2","currency":"USD","unitRateINR":"371963718.4","date":"17-Jun-2022","totalValueINR":"911311.11","totalValueInUsd":"11681.2","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"9148603","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1667759400,"product":"TEDUGLUTIDE API (FOR TESTING PURPOSE ONLY)","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"CHINESE PEPTIDE CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"4500","totalValueFC":"26183.4","currency":"USD","unitRateINR":"427380","date":"07-Nov-2022","totalValueINR":"2136900","totalValueInUsd":"26183.4","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"3198700","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730053800,"product":"TEDUGLUTIDE - 802533","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CHINESE PEPTIDE CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"5000","totalValueFC":"28105.5","currency":"USD","unitRateINR":"472322","date":"28-Oct-2024","totalValueINR":"2361610","totalValueInUsd":"28105.5","indian_port":"Bangalore Air","hs_no":"29371900","bill_no":"6383363","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.69,12TH STREET,HANGZHOU ECONOMIC & TECHNOLOGICAL DEVELOPMENT ZONE,C HINA 310018 China","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735497000,"product":"TEDUGLUTIDE (FOR LABORATORY RESEARCH USE ONLY) TEDUGLUTIDE (FOR LABORATORY RESEARCH USE ONLY)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"CHINESE PEPTIDE COLTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"2750","totalValueFC":"16448.5","currency":"USD","unitRateINR":"279523","date":"30-Dec-2024","totalValueINR":"1397614.8","totalValueInUsd":"16448.5","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"7518972","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO.69,12TH STREET,HANGZHOU ECONOMIC & TECHNOLOGICAL DEVELOPMENT ZONE,C HINA 310018 China","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746988200,"product":"D-HIST1-TEDUGLUTIDE - 971712 (QTY 50 MG) D-HIST1-TEDUGLUTIDE - 971712 (QTY 50 MG)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CHINESE PEPTIDE CO","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00005","unit":"KGS","unitRateFc":"122599960","totalValueFC":"6155.1","currency":"USD","unitRateINR":"10488427200","date":"12-May-2025","totalValueINR":"524421.36","totalValueInUsd":"6155.1","indian_port":"Bangalore Air","hs_no":"29371900","bill_no":"2002802","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"No.69 12th Street,Hangzhou Economic & Technological Development Zone,C hina-310018 China","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746988200,"product":"ENDO-SER7 TEDUGLUTIDE - 714394 (QTY 50 MG) ENDO-SER7 TEDUGLUTIDE - 714394 (QTY 50 MG)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CHINESE PEPTIDE CO","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00005","unit":"KGS","unitRateFc":"122599960","totalValueFC":"6155.1","currency":"USD","unitRateINR":"10488427200","date":"12-May-2025","totalValueINR":"524421.36","totalValueInUsd":"6155.1","indian_port":"Bangalore Air","hs_no":"29371900","bill_no":"2002802","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"No.69 12th Street,Hangzhou Economic & Technological Development Zone,C hina-310018 China","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746988200,"product":"[BASP11]-TEDUGLUTIDE - 714391 (QTY 50 MG) [BASP11]-TEDUGLUTIDE - 714391 (QTY 50 MG)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CHINESE PEPTIDE CO","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00005","unit":"KGS","unitRateFc":"122599960","totalValueFC":"6155.1","currency":"USD","unitRateINR":"10488427200","date":"12-May-2025","totalValueINR":"524421.36","totalValueInUsd":"6155.1","indian_port":"Bangalore Air","hs_no":"29371900","bill_no":"2002802","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"No.69 12th Street,Hangzhou Economic & Technological Development Zone,C hina-310018 China","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746988200,"product":"[BASP16]-TEDUGLUTIDE - 714392 (QTY 50 MG) [BASP16]-TEDUGLUTIDE - 714392 (QTY 50 MG)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CHINESE PEPTIDE CO","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00005","unit":"KGS","unitRateFc":"122599960","totalValueFC":"6155.1","currency":"USD","unitRateINR":"10488427200","date":"12-May-2025","totalValueINR":"524421.36","totalValueInUsd":"6155.1","indian_port":"Bangalore Air","hs_no":"29371900","bill_no":"2002802","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"No.69 12th Street,Hangzhou Economic & Technological Development Zone,C hina-310018 China","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746988200,"product":"[BASP21]-TEDUGLUTIDE - 977402 (QTY 50 MG) [BASP21]-TEDUGLUTIDE - 977402 (QTY 50 MG)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CHINESE PEPTIDE CO","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00005","unit":"KGS","unitRateFc":"122599960","totalValueFC":"6155.1","currency":"USD","unitRateINR":"10488427200","date":"12-May-2025","totalValueINR":"524421.36","totalValueInUsd":"6155.1","indian_port":"Bangalore Air","hs_no":"29371900","bill_no":"2002802","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"No.69 12th Street,Hangzhou Economic & Technological Development Zone,C hina-310018 China","customerAddress":"564\/A\/22, ROAD NO.92"}]
17-Jun-2022
16-Sep-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 15, 2025

blank

01

BIO Partnering at JPM
Not Confirmed
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

May 15, 2025

blank

Details:

Under the collaboration, OPKO will supply its proprietary long-acting GLP-2 peptide and certain Oxyntomodulin analogs, including Teduglutide, the only approved GLP-2 analog, for the development of oral tablet formulations using Entera’s proprietary oral delivery technology.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

Study Phase: PreclinicalProduct Type: Peptide, Unconjugated

Sponsor: OPKO Biologics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration September 12, 2023

blank

02

EnteraBio Ltd

Israel
arrow
BIO Partnering at JPM
Not Confirmed

EnteraBio Ltd

Israel
arrow
BIO Partnering at JPM
Not Confirmed

Details : Under the collaboration, OPKO will supply its proprietary long-acting GLP-2 peptide and certain Oxyntomodulin analogs, including Teduglutide, the only approved GLP-2 analog, for the development of oral tablet formulations using Entera’s proprietary ora...

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Undisclosed

September 12, 2023

blank

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 30, 2021

blank

03

BIO Partnering at JPM
Not Confirmed
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

August 30, 2021

blank

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Peptide, Unconjugated

Sponsor: Takeda Pharmaceutical

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 10, 2020

blank

04

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

July 10, 2020

blank
  • Development Update

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: SHIRE PLC

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 16, 2019

blank

05

Allegheny Singer Research Institute

Country
arrow
BIO Partnering at JPM
Not Confirmed

Allegheny Singer Research Institute

Country
arrow
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

May 16, 2019

blank

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 10, 2018

blank

06

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

September 10, 2018

blank

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 23, 2018

blank

07

BIO Partnering at JPM
Not Confirmed
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

July 23, 2018

blank

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 27, 2018

blank

08

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

June 27, 2018

blank

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Takeda Pharmaceutical

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 31, 2017

blank

09

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

August 31, 2017

blank

Details:

Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.


Lead Product(s): Teduglutide,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 02, 2016

blank

10

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

SHIRE PLC

United Kingdom
arrow
BIO Partnering at JPM
Not Confirmed

Details : Teduglutide is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Short Bowel Syndrome.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

December 02, 2016

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

TEDUGLUTIDE

US Patent Number : 9060992

Drug Substance Claim :

Drug Product Claim :

Application Number : 203441

Patent Use Code : U-1320

Delist Requested : Y

Patent Use Description : TREATMENT OF ADULT PAT...

Patent Expiration Date : 2025-11-01

blank

02

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

TEDUGLUTIDE

US Patent Number : 7847061

Drug Substance Claim :

Drug Product Claim :

Application Number : 203441

Patent Use Code : U-1320

Delist Requested : Y

Patent Use Description : TREATMENT OF ADULT PAT...

Patent Expiration Date : 2025-11-01

blank

03

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

TEDUGLUTIDE

US Patent Number : 7847061*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 203441

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-01

blank

04

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

TEDUGLUTIDE

US Patent Number : 9060992*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 203441

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-05-01

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

TEDUGLUTIDE

Exclusivity Code : ODE-240

Exclusivity Expiration Date : 2026-05-16

Application Number : 203441

Product Number : 1

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for / Teduglutide API manufacturers, exporters & distributors?

Teduglutide manufacturers, exporters & distributors 1

78

PharmaCompass offers a list of Teduglutide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Teduglutide manufacturer or Teduglutide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Teduglutide manufacturer or Teduglutide supplier.

PharmaCompass also assists you with knowing the Teduglutide API Price utilized in the formulation of products. Teduglutide API Price is not always fixed or binding as the Teduglutide Price is obtained through a variety of data sources. The Teduglutide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Teduglutide

Synonyms

Chebi:72305, Teduglutide (rdna origin), Chembl2104987, Bdbm50183895

GATTEX KIT Manufacturers

A GATTEX KIT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GATTEX KIT, including repackagers and relabelers. The FDA regulates GATTEX KIT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GATTEX KIT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of GATTEX KIT manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

GATTEX KIT Suppliers

A GATTEX KIT supplier is an individual or a company that provides GATTEX KIT active pharmaceutical ingredient (API) or GATTEX KIT finished formulations upon request. The GATTEX KIT suppliers may include GATTEX KIT API manufacturers, exporters, distributors and traders.

click here to find a list of GATTEX KIT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

GATTEX KIT USDMF

A GATTEX KIT DMF (Drug Master File) is a document detailing the whole manufacturing process of GATTEX KIT active pharmaceutical ingredient (API) in detail. Different forms of GATTEX KIT DMFs exist exist since differing nations have different regulations, such as GATTEX KIT USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A GATTEX KIT DMF submitted to regulatory agencies in the US is known as a USDMF. GATTEX KIT USDMF includes data on GATTEX KIT's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The GATTEX KIT USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of GATTEX KIT suppliers with USDMF on PharmaCompass.

GATTEX KIT WC

A GATTEX KIT written confirmation (GATTEX KIT WC) is an official document issued by a regulatory agency to a GATTEX KIT manufacturer, verifying that the manufacturing facility of a GATTEX KIT active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting GATTEX KIT APIs or GATTEX KIT finished pharmaceutical products to another nation, regulatory agencies frequently require a GATTEX KIT WC (written confirmation) as part of the regulatory process.

click here to find a list of GATTEX KIT suppliers with Written Confirmation (WC) on PharmaCompass.

GATTEX KIT NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing GATTEX KIT as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for GATTEX KIT API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture GATTEX KIT as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain GATTEX KIT and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a GATTEX KIT NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of GATTEX KIT suppliers with NDC on PharmaCompass.

GATTEX KIT GMP

GATTEX KIT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of GATTEX KIT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GATTEX KIT GMP manufacturer or GATTEX KIT GMP API supplier for your needs.

GATTEX KIT CoA

A GATTEX KIT CoA (Certificate of Analysis) is a formal document that attests to GATTEX KIT's compliance with GATTEX KIT specifications and serves as a tool for batch-level quality control.

GATTEX KIT CoA mostly includes findings from lab analyses of a specific batch. For each GATTEX KIT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

GATTEX KIT may be tested according to a variety of international standards, such as European Pharmacopoeia (GATTEX KIT EP), GATTEX KIT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GATTEX KIT USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty